Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke
暂无分享,去创建一个
Jian Cheng | Z. Hua | J. Jia | Yunqi Xiao | Hui Liu | Yi Wang
[1] Yonghua Cui,et al. Hydrogen Sulfide Ameliorates Early Brain Injury Following Subarachnoid Hemorrhage in Rats , 2016, Molecular Neurobiology.
[2] N. Tyagi,et al. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer’s Disease-Like Pathology, Blood–Brain Barrier Disruption, and Synaptic Disorder , 2016, Molecular Neurobiology.
[3] Jun Chen,et al. White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke , 2015, Experimental Neurology.
[4] X. Ji,et al. Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model , 2015, Experimental Neurology.
[5] J. Wallace,et al. Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter , 2015, Nature Reviews Drug Discovery.
[6] Ying Sun,et al. Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux. , 2015, Biochemical and biophysical research communications.
[7] Ying-jie Geng,et al. Hydrogen Sulfide Inhalation Decreases Early Blood—Brain Barrier Permeability and Brain Edema Induced by Cardiac Arrest and Resuscitation , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] Sherif Hafez,et al. Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA , 2015, Translational Stroke Research.
[9] N. Alkayed,et al. Preclinical Evaluation of Recombinant T Cell Receptor Ligand RTL1000 as a Therapeutic Agent in Ischemic Stroke , 2015, Translational Stroke Research.
[10] Jian Cheng,et al. Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke , 2014, Brain, Behavior, and Immunity.
[11] N. Alkayed,et al. Recombinant T Cell Receptor Ligand Treatment Improves Neurological Outcome in the Presence of Tissue Plasminogen Activator in Experimental Ischemic Stroke , 2014, Translational Stroke Research.
[12] N. Alkayed,et al. Hydrogen sulfide protects blood–brain barrier integrity following cerebral ischemia , 2014, Journal of neurochemistry.
[13] D. Stein,et al. Progesterone Attenuates Hemorrhagic Transformation after Delayed tPA Treatment in an Experimental Model of Stroke in Rats: Involvement of the VEGF–MMP Pathway , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] Yi-Zhun Zhu,et al. VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells. , 2013, Antioxidants & redox signaling.
[15] J. Moser,et al. Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. , 2013, Journal of the American Society of Nephrology : JASN.
[16] J. Sadoshima,et al. Thioredoxin 1 Is Essential for Sodium Sulfide–Mediated Cardioprotection in the Setting of Heart Failure , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[17] N. Alkayed,et al. Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke , 2013, Neuroscience.
[18] Hong Wang,et al. Hydrogen Sulfide Protects HUVECs against Hydrogen Peroxide Induced Mitochondrial Dysfunction and Oxidative Stress , 2013, PloS one.
[19] Ping Cai,et al. Recombinant ADAMTS13 reduces tissue plasminogen activator‐induced hemorrhage after stroke in mice , 2013, Annals of neurology.
[20] M. Nicholson,et al. Effects of hydrogen sulphide in an experimental model of renal ischaemia–reperfusion injury , 2012, The British journal of surgery.
[21] D. Atochin,et al. A Novel Hydrogen Sulfide-releasing N-Methyl-d-Aspartate Receptor Antagonist Prevents Ischemic Neuronal Death* , 2012, The Journal of Biological Chemistry.
[22] Jeremy Seto,et al. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. , 2012, The Journal of clinical investigation.
[23] R. Swanson,et al. Hyperglycemia promotes tissue plasminogen activator‐induced hemorrhage by Increasing superoxide production , 2011, Annals of neurology.
[24] A. Papapetropoulos,et al. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function , 2011, Proceedings of the National Academy of Sciences.
[25] J. Bian,et al. Hydrogen sulfide: neurophysiology and neuropathology. , 2011, Antioxidants & redox signaling.
[26] M. Whiteman,et al. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising , 2011, Expert review of clinical pharmacology.
[27] Y. Zhu,et al. Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators , 2011, Expert review of clinical pharmacology.
[28] J. An,et al. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. , 2008, Blood.
[29] M. Kaste,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.
[30] O. Witte,et al. Early Disruption of the Blood–Brain Barrier After Thrombolytic Therapy Predicts Hemorrhage in Patients With Acute Stroke , 2008, Stroke.
[31] Ulf Eriksson,et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.
[32] P. Moore,et al. Characterization of a Novel, Water-Soluble Hydrogen Sulfide–Releasing Molecule (GYY4137): New Insights Into the Biology of Hydrogen Sulfide , 2008, Circulation.
[33] Sumit R. Majumdar,et al. Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis , 2008, Diabetes Care.
[34] L. Oesterhelweg,et al. Phenomenological and morphological aspects of fatalities caused by manure gas , 2008 .
[35] L. Oesterhelweg,et al. “Death may come on like a stroke of lightening ...” , 2008, International Journal of Legal Medicine.
[36] Csaba Szabo,et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function , 2007, Proceedings of the National Academy of Sciences.
[37] P. Moore,et al. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. , 2007, Journal of applied physiology.
[38] E. Kılıç,et al. The phosphatidylinositol‐3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] B. Halliwell,et al. Hydrogen Sulfide Is a Mediator of Cerebral Ischemic Damage , 2006, Stroke.
[40] J. M. Wardlaw,et al. Thrombolytic Therapy With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke: Where Do We Go From Here? A Cumulative Meta-Analysis , 2003, Stroke.
[41] Eng H. Lo,et al. Neurological diseases: Mechanisms, challenges and opportunities in stroke , 2003, Nature Reviews Neuroscience.
[42] B. Rosen,et al. Rapid Breakdown of Microvascular Barriers and Subsequent Hemorrhagic Transformation After Delayed Recombinant Tissue Plasminogen Activator Treatment in a Rat Embolic Stroke Model , 2002, Stroke.
[43] Hamid Soltanian-Zadeh,et al. Correlation of VEGF and Angiopoietin Expression with Disruption of Blood–Brain Barrier and Angiogenesis after Focal Cerebral Ischemia , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[44] M Chopp,et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. , 2000, The Journal of clinical investigation.
[45] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[46] Y. Ukai,et al. Chronic anethole trithione treatment enhances the salivary secretion and increases the muscarinic acetylcholine receptors in the rat submaxillary gland. , 1984, Archives internationales de pharmacodynamie et de therapie.